Psychotropic and nonpsychotropic cannabis derivatives inhibit human 5-HT(3A) receptors through a receptor desensitization-dependent mechanism. by 援щ낯��
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INHIBIT HUMAN 5-HT3A RECEPTORS THROUGH A RECEPTOR
ESENSITIZATION-DEPENDENT MECHANISM
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Abstract—9 tetrahydrocannabinol (THC) and cannabidiol
(CBD) are the principal psychoactive and nonpsychoactive
components of cannabis. While most THC-induced behav-
ioral effects are thought to depend on endogenous cannabi-
noid 1 (CB1) receptors, the molecular targets for CBD remain
unclear. Here, we report that CBD and THC inhibited the
function of human 5-HT3A receptors (h5-HT3ARs) expressed
n HEK 293 cells. The magnitude of THC and CBD inhibition
as maximal 5 min after a continuous incubation with can-
abinoids. The EC50 values for CBD and THC-induced inhibi-
tion were 110 nM and 322 nM, respectively in HEK 293 cells
expressing h5-HT3ARs. In these cells, CBD and THC did not
timulate specific [35S]-GTP-s binding in membranes, sug-
gesting that the inhibition by cannabinoids is unlikely medi-
ated by a G-protein dependent mechanism. On the other
hand, both CBD and THC accelerated receptor desensitiza-
tion kinetics without significantly changing activation time.
The extent of cannabinoid inhibition appeared to depend on
receptor desensitization. Reducing receptor desensitization
by nocodazole, 5-hydroxyindole and a point-mutation in the
large cytoplasmic domain of the receptor significantly de-
creased CBD-induced inhibition. Similarly, the magnitude of
THC and CBD-induced inhibition varied with the apparent
desensitization rate of h5-HT3ARs expressed in Xenopus
oocytes. For instance, with increasing amount of h5-HT3AR
cRNA injected into the oocytes, the receptor desensitiza-
tion rate at steady state decreased. THC and CBD-induced
inhibition was correlated with the change in the receptor
desensitization rate. Thus, CBD and THC inhibit h5-HT3A
receptors through a mechanism that is dependent on re-
ceptor desensitization. Published by Elsevier Ltd on behalf
of IBRO.
Key words: cannabis, CBD, THC, 5-HT3A, desensitization,
ligand-gated ion channel.
While 9-tetrahydrocannabinol (THC) is a psychoactive
ubstance, cannabidiol (CBD) has been known as the
ain nonpsychoactive component of marijuana (Pertwee,
005; Pacher et al., 2006). CBD is the most abundant
annabinoid in marijuana next to THC. Like THC, CBD has
*Corresponding author. Tel: 1-301-435-1920; fax: 1-301-480-0466.
-mail address: xiongw@mail.nih.gov (W. Xiong).
bbreviations: AEA, anandamide; ANOVA, analysis of variance; CBD,
annabidiol; DA, dopamine; h5-HT3ARs, human 5-HT3A receptors;
GIC, ligand-gated ion channel; Noc, nocodazole; OCB, open channel
9c
lockers; THC,  tetrahydrocannabinol; TM, transmembrane domain;
TA, ventral tegmental area; WT, wild type; 5-HOID, 5-hydroxyindole.
0306-4522/11 $ - see front matter. Published by Elsevier Ltd on behalf of IBRO.
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28een known for its therapeutic potential in the treatment of
pilepsy, glaucoma, central and peripheral inflammatory
isorders, anxiety, acute schizophrenia, and cancer (Izzo
t al., 2009; Scuderi et al., 2009). Both CBD and THC have
een shown to be effective for the management of pain
nd emetic action induced by chemotherapy in humans
Pertwee, 2005). In contrast to THC, CBD has been found
o inhibit psychotic effects induced by cannabis in humans
Leweke et al., 2000). Although CBD and THC share a
igh degree of similarity in their chemical structures, they
ct on the brain through distinct mechanisms (Pacher et
l., 2006). While the majority of THC-induced behavioral
ffects are thought to involve activation of endogenous
annabinoid type 1 (CB1) receptors, the molecular targets
or CBD-induced action remain unknown since CBD does
ot activate CB1 and CB2 receptors (Pertwee, 2005).
merging evidence has also suggested that some of the
HC-induced effects are not dependent on CB1 receptors.
or instance, both THC and CBD can exert neuroprotec-
ive effect against NMDA receptor-induced neurotoxicity
hrough a CB1 receptor-independent mechanism (Hamp-
on et al., 1998). THC has also been found to directly
nhibit the function of recombinant human 5-HT3A recep-
tors (h5-HT3ARs) expressed in HEK 293 cells (Barann et
al., 2002). A recent study has suggested that 5-HT3 recep-
ors are involved in CB1/CB2 independent cannabinoid-
nduced analgesia in vivo (Racz et al., 2008).
5-HT3Rs are a member of a ligand-gated ion channel
(LGIC) superfamily including GABA, glycine, and neuronal
nicotinic acetylcholine (nACh) receptors. 5-HT3Rs are in-
olved in pain transmission, analgesia, mood disorders,
nd drug abuse (Zhang and Lummis, 2006). Selective
ntagonists of 5-HT3R produce anxiolytic and antiemetic
effects in animal models (Zhang and Lummis, 2006). Ho-
mopentameric receptors containing only the 5-HT3AR sub-
nit are capable of forming functional ion channels in the
NS (Maricq et al., 1991; Morales and Wang, 2002).
-HT3ARs play a role in reward mechanism and actions of
drug abuse (Grant, 1995).
One common feature shared by the members of LGICs
is that these receptors desensitize rapidly in the prolonged
presence of agonists. Although the molecular processes of
receptor desensitization remain elusive, receptor desensi-
tization has been shown to contribute significantly to acute
ethanol interaction with the function of 5-HT3Rs and
AChRs (Zhou et al., 1998; Dopico and Lovinger, 2009). A
umber of factors can affect 5-HT3R desensitization. De-
ensitization kinetics can be affected by external calcium
oncentrations (Hu and Lovinger, 2005), posttranslational
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W. Xiong et al. / Neuroscience 184 (2011) 28–37 29modification of receptor protein by activation of protein
kinases (Yakel et al., 1991; Hubbard et al., 2000), cyto-
keleton proteins (Emerit et al., 2005), and subunit com-
osition (Hapfelmeier et al., 2003). Although the mecha-
isms of LGIC desensitization remain elusive, receptor
esensitization is thought to contribute to controlling and
haping the efficacy of synaptic signaling (Jones and
estbrook, 1996; Giniatullin et al., 2005).
Like THC, CBD has been used for the treatment of
nticancer drug-induced vomiting and nausea (Pertwee,
005). The antiemetic action of cannabis has been pro-
osed to occur partially via inhibition of 5-HT3 receptors
(Townsend et al., 2002). However, whether or not CBD
can inhibit h5-HT3ARs and the mechanism underlying can-
nabinoid inhibition have not been reported. To address
these questions, we examined the effects of both CBD and
THC on 5-HT-activated current in HEK 293 cells and Xe-
nopus oocytes expressing h5-HT3ARs. Our results show
hat like THC, CBD potently inhibits h5-HT3AR function in a
anner that is independent of agonist concentration. Both
BD and THC accelerate receptor desensitization. In ad-
ition, the extent of h5-HT3AR desensitization appears to
influence the ability of cannabinoid-induced receptor inhi-
bition. Some of this work has been presented previously in
a preliminary form (Sun et al., 2009).
EXPERIMENTAL PROCEDURES
HEK 293 cell transfection and whole cell recording
HEK 293 cells were cultured as described previously (Xiong et al.,
2008). The plasmid cDNA coding for the h5-HT3AR was trans-
fected with the SuperFect Transfection kit (Qiagen, Valencia, CA,
USA). Currents were recorded 24–48 h after transfection. Cells
were lifted and continuously superfused with a solution containing
140 mM NaCl, 5 mM KCl, 1.8 mM CaCl2, 1.2 mM MgCl2, 5 mM
glucose, and 10 mM HEPES (pH 7.4 with NaOH; 340 mosmol
with sucrose). Membrane currents were recorded in the whole-cell
configuration using an Axopatch 200B amplifier (Axon Instruments
Inc., Burlingame, CA, USA) at 20–22 °C. Cells were held at 60
mV unless otherwise indicated. Data were acquired using
pCLAMP 9 software (Molecular Devices, Sunnyvale, CA, USA).
Bath solutions were applied through three barrel square glass
tubing (Warner Instrument, Hamden, CT, USA) with tip diameter
of 200 m. Drugs were applied using a Warner fast-step step-
per-motor driven system. The 10–90% rise time of the junction
potential during whole-cell recording was 4–12 ms.
Site-directed mutagenesis
Point-mutations of a cloned h5-HT3A subunit were introduced
sing a QuikChange Site-Directed Mutagenesis Kit (Stratagene,
a Jolla, CA, USA). The authenticity of the DNA sequence through
he mutation sites was confirmed by double strand DNA sequenc-
ng using a CEQ 8000 Genetic Analysis System (Beckman
oulter, Inc., Brea, CA, USA).
[35S]-GTP-s binding
HEK 293 cells were collected and homogenized in ice cold 50 mM
Tris–HCl, pH 7.4. The homogenate was centrifuged at 30,000 g
for 10 min at 4 °C. The membrane pellet was suspended in binding
buffer used for [35S]-GTP-s (PerkinElmer, Boston, MA, USA)
inding reaction, which contains 20 mM HEPES, 100 mM NaCl, 6
M MgCl2, 0.1 mM DTT, and 5 M GDP. The membranes wereincubated with 0.1 nM [35S]-GTP-s for 2 h at 30 °C. The filters
were washed twice with 4 ml cold 10 mM Tri–HCl. Nonspecific
binding was determined by 40 M of GTP-s. Bound and free
35S]-GTP-s was separated by rapid vacuum filtration in a Bran-
ell harvester through GF/B filters. The filters were punched into
cintillation vials containing 5 ml liquid scintillation cocktail (LSC).
he samples were counted in a scintillation counter at 50% effi-
iency. Assays were performed in triplicate and each experiment
as repeated at least three times.
Preparation of cRNAs and expression of receptors
The cDNA clone of the h5-HT3A subunit was purchased fromOriGen,
Inc (Rockville, MD, USA). Complementary RNAs (cRNAs) were syn-
thesized in vitro using an mMESSAGE mMACHINE RNA transcrip-
tion kit (Ambion Inc., Austin, TX, USA). The quality and sizes of
synthesized cRNAs were confirmed by denatured RNA agarose
gels. Mature female Xenopus laevis frogs were anesthetized by
submersion in 0.2% 3-aminobenzoic acid ethyl ester (Sigma, St
Louis, MO, USA). Oocytes were surgically excised and sepa-
rated. The follicular cell layer of the oocytes was removed by
treatment with type A collagenase (Sigma-Aldrich) for 10 min at
room temperature. Although the amount of cRNA injected into
oocytes varied from 1 to 100 ng, as indicated, the injection volume
of diethylpyrocarbonate (DEPC)-treated water was kept at 20 nl
for all injections. Oocytes were incubated at 19 °C in modified
Barth’s solution (MBS): 88 mM NaCl, 1 mM KCl, 2.4 mM NaHCO3,
.0 mM CaCl2, 0.8 mM MgSO4, 10 mM HEPES, pH 7.4.
Xenopus oocyte electrophysiological recording
After incubation for 2–5 days, oocytes were studied at room
temperature (20–22 °C) in a 90 l chamber. The oocytes were
superfused with MBS at a rate of 6 ml/min. Agonists and chemical
agents were diluted in the bath solution and applied to the oocytes
for a specified time, using a solenoid valve-controlled superfusion
system. Membrane currents were recorded by two-electrode volt-
age-clamp at a holding potential of 70 mV, using a Gene Clamp
500 amplifier (Axon Instruments Inc., Burlingame, CA, USA). The
recording microelectrodes were filled with 3 M KCl and had elec-
trical resistances of 0.5–3.0 M. Data were acquired using
pClamp 9.1 software (Axon). Average values are expressed as
meansSE.
Data analysis
Statistical analysis of concentration-response data was performed
with the use of the nonlinear curve-fitting program Prism. Data
were fit using the Hill equation
I/Imax.1/[1(EC50/[Agonist])
nH]
here I is the current amplitude activated by a given concentra-
ion of agonist ([Agonist]), Imax is the maximum response of the
cell, nH is the Hill coefficient and EC50 is the concentration eliciting
half-maximal response. Data were statistically compared by the
npaired t-test, or analysis of variance (ANOVA), as noted. Aver-
ge values are expressed as meanstandard error (SE).
Kinetic measurements
Activation rate of current induced by 30 M 5-HT was estimated
by measuring the slope of the initial inward component of current
between 10 and 30% of the maximal current (10–30% rise time).
Receptor desensitization was induced by prolonging incubation
with 5-HT plus CBD or THC for 30 s. The time constants of
deactivation and desensitization were determined by fitting with
exponential functions using the Marquardt-Levenberg algorithm in
Clampfit. The desensitization time constants for 5-HT R-mediated3
currents were best fit using a bi-exponential function when ex-
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W. Xiong et al. / Neuroscience 184 (2011) 28–3730pressed in HEK 293 cells. However, a single exponential function
was sufficient to accurately fit the desensitization decays of cur-
rent activated by 5-HT in the presence of CBD or THC. While
comparing single to multiple exponential data, a weighted sum of
the fast and slow components (AFAST*FASTASLOW*SLOW) was
used to normalize the two components into a single component,
where as FAST and SLOW were the fast and slow decay time
constants, and AFAST and ASLOW were the relative proportions of
the fast and slow components.
Chemicals
All chemicals used in preparing the solutions were from Sigma-
Aldrich (St. Louis, MO, USA). 5-HT was applied by gravity flow
via a micropipette positioned 3 mm from the oocyte. Stock
solutions of AEA, 5-hydroxyindole (5-HOID), and nocodazole
(Noc) were prepared at a concentration of 10 mM in dimethyl-
sulfoxide (DMSO). DMSO alone did not affect 5-HT receptors
when added at concentrations up to 0.2% (v/v), which was
twice as high as the highest concentration of DMSO used in our
experiments.
RESULTS
CBD and THC inhibit h5-HT3AR-mediated responses
CBD and THC are structurally similar (Fig. 1A). THC at 1
M reduced the amplitude of 5-HT (30 M)-induced cur-
ents in HEK 293 cells expressing h5-HT3A subunits (Fig.
1A). This observation is consistent with a previous study
(Barann et al., 2002). Similarly, CBD at 1 M inhibited
Fig. 1. CBD and THC inhibition of h5-HT3ARs expressed in HEK 293 c
ctivated by 30 M 5-HT without and with preincubation of 1 M THC
application. The arrows indicate the preincubation without or with TH
raphs represent average percent of control current amplitude after T
f continuous application of THC. The open bar indicates the time of
east nine cells. The error bars that are invisible are smaller than the s
f I5-HT. The curves are best fit using the Hill equation as described in “four cells. (D) Apparent noncompetitive inhibition of h5-HT3AR-mediated respo
urves in the absence (open circles) and in the presence of 1 M CBD (solid5-HT3A receptor-mediated current (Fig. 1A). The inhibition
y 1 MCBD and THC was developed gradually after drug
application, and reached a maximal level 3–5 min after
continuous applications of the drugs (Fig. 1B). The mag-
nitudes of the maximal inhibition by THC and CBD were
975% and 8213%. These values were not significantly
different (P0.1, unpaired t-test, n5). The inhibition by
CBD and THC were reversible after discontinuation of drug
application (Fig. 1B). CBD and THC inhibited the amplitude
of 5-HT-activated current in a concentration-dependent
manner in HEK 293 cells expressing h5-HT3ARs (Fig. 1C).
However, THC appeared to be more potent than CBD in
inhibiting h5-HT3ARs. The EC50 values were 11913 nM
for THC and 32919 nM for CBD. These values were
significantly different (P0.001, unpaired t-test, n4). The
hill slope values were 1.590.48 for THC and 1.340.13
for CBD.
The CBD-induced inhibition of h5-HT3ARs was also
examined in the presence of different concentrations of
5-HT (Fig. 1D). CBD inhibited h5-HT3ARs in a manner that
as independent of agonist concentration. CBD at 1 M
educed the amplitude of current activated by 1, 3, 10, and
0 M 5-HT by 8210%, 789%, 8411%, and 8213%.
These values were not significantly different (one-way
ANOVA followed by Dunnett’s posthoc test, P	0.2, n6).
Moreover, CBD did not significantly alter the EC50 and
lope values of the 5-HT-concentration response curve
he chemical structures of THC and CBD and traces showing currents
for 3 min. The solid bar above each trace indicates the time of 5-HT
. (B) Time courses of THC and CBD inhibition of 5-HT3A receptors.
gles) and CBD (squares) application. The solid bar indicates the time
s application of CBD. Each data point represents meanSE from at
bols. (C) Concentration-response curves for CBD and THC inhibition
ntal procedures”. Each data point represents meanSE from at leastells. (A) T
or CBD
C or CBD
HC (trian
continuou
ize of sym
Experimense by 1 M CBD. Graphs represent 5-HT concentration-response
circles).
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W. Xiong et al. / Neuroscience 184 (2011) 28–37 31(2.20.2 M and 1.30.2 in the absence of CBD, 2.50.1
M and 1.51.0 in the presence of 1 M CBD, P0.2,
unpaired t-test).
CBD and THC do not directly stimulate [35S]-GTP-s
inding
lthough CBD is not the agonist of cloned CB1 and CB2
eceptors, there is evidence to suggest that CBD may act
n certain types of unknown CB-like receptors (Begg et al.,
003). To exclude the possibility that CBD may modulate
-HT3A receptors by activating unknown G-protein-cou-
led receptors endogenously expressed in HEK 293 cells,
e directly measured the specific binding of [35S]-GTP-s
in HEK 293 cells. Morphine, a mu-opioid receptor agonist,
at 1 M, stimulated specific [35S]-GTP-s binding by
31%, 272% and 367% of control at increasing time
oints after agonist addition in HEK 293 cells expressing
u-opioid receptors (Fig. 2). In contrast, in cells without
otransfection of mu-opioid receptors, morphine did not
ignificantly affect the basal level of specific [35S]-GTP-s
binding (0.31%, 2.44.5%, and 4.93%). The values of
morphine-induced specific [35S]-GTP-s binding at each
oint of incubation time significantly differed in cells with
nd without cotransfection of mu-opioid receptors
P0.004, unpaired t-test, n5). This finding is in line with
previous observation (Xu et al., 2003). Next, we exam-
ned the effects of CBD and THC on specific [35S]-GTP-s
inding at various incubation times. CBD and THC at 1 M
did not significantly stimulate the specific [35S]-GTP-s
binding after 2 h incubation (Fig. 2).
CBD accelerates receptor desensitization
To further explore the mechanisms underlying CBD-in-
duced inhibition, we examined the effects of CBD on the
gating kinetics of h5-HT3ARs expressed in HEK 293 cells.
n these cells, CBD was found to accelerate the decay of
Fig. 2. CBD and THC do not stimulate [35S]-GTP-s binding. Graphs
represent the time course of specific [35S]-GTP-s binding in the
resence of 1 M morphine, CBD, and THC in HEK 293 cells without
(open circles, control) and with (solid circles) transient transfection of
mu-opioid receptor cDNA. Each data point represents the average
percent of control from at least five separate experiments. Asterisks
indicate a significant difference as compared with control. * P0.05;
** P0.01.-HT-activated currents (Fig. 3A). The values of the 10–
0% rise time of 5-HT-activated currents were 2.90.1 ms
nd 2.80.2 ms in the absence and presence of 0.1 M
BD in HEK 293 cells expressing h5-HT3ARs (Fig. 3B).
These values were not significantly different (unpaired t-
test, P0.2, n11). However, CBD appeared to acceler-
ate the decay of 5-HT-activated current (desensitization) in
the continuous presence of 5-HT (Fig. 3C). To properly
evaluate the effect of CBD on desensitization kinetics, we
normalized the fast and slow components using the
weighted sum formula described in “Methods.” In HEK 293
cells, the values of the normalized desensitization time
Fig. 3. CBD accelerates receptor desensitization kinetics. (A) Trac-
ings of 5-HT-activated currents without and with preincubation of 1 M
BD for 3 min recorded from a HEK 293 cell expressing h5-HT3ARs.
he amplitude of current in the presence of CBD was normalized to
hat in the absence of CBD. The arrow indicates the preincubation of
BD. (B) Bar graphs represent the average activation times of 5-HT-
ctivated current with and without preincubation of 1 M CBD for 3
in. Each data point represents meanSE from seven cells. (C) Bar
raphs represent the average weighted desensitization time constant
f 5-HT-activated current with and without preincubation of 1 M CBD
for 3 min. Each data point represents meanSE from seven cells.
Asterisks indicate a significant difference as compared with control.
* P0.05.constant were 57681 ms and 18111 ms in the absence
1
s
h
c
h
a
5
s
a
a
a
m
a
I
p
a
t
o
t
o
5
d
r
C
r
N
c
i
p
4
H
d
s
s
a
s
i
i
i
W. Xiong et al. / Neuroscience 184 (2011) 28–3732and presence of CBD, suggesting that CBD significantly
accelerated the desensitization rate of h5-HT3ARs (un-
paired t-test, P0.001, n9).
CBD-induced inhibition varies with the different
receptor desensitization rates
The observations noted above suggest that CBD can ac-
celerate receptor desensitization. We next asked whether
altering receptor desensitization will change CBD inhibi-
tion. We first treated cells with 5-hydroxyindole (5-HOID) or
nocodazole (Noc) since these agents have been found to
slow 5-HT3 receptor desensitization (van Hooft et al.,
997; Hu et al., 2006; Sun et al., 2008). Moreover, we
ubstituted a positively charged residue, arginine, with a
ydrophobic residue, leucine, at position of 427 in the large
ytoplasmic domain of the 5-HT3A subunit. This mutation
as been reported to slow receptor desensitization (Hu et
l., 2006). Consistent with previous studies, application of
M 5-HOID or pretreatment with 25 M Noc for 4 h
lowed the decay of 5-HT-activated current (Fig. 4A). The
Fig. 4. 5-HOID, Noc and the R427L mutation alters receptor desen-
sitization and CBD-induced inhibition. (A) Tracings of 5-HT-activated
currents without and with preincubation of 1 M CBD for 3 min in HEK
293 cells expressing the wild type and the R427L mutant 5-HT3A
receptors. 5 M 5-HOID was applied simultaneously with 5-HT to
cells. Cells were pretreated with 25 M Noc for 4 h and washed
thoroughly during the recording. The arrows indicate the preincubation
of CBD. (B) The open bars represent the average percent inhibition
induced by 1 M CBD. The solid bars represent average weighted
esensitization time constant with and without treatment to alter de-
ensitization. The average weighted time constant of receptor desen-
itization is the sum of fast and slow components of h5-HT3A receptor,
s described in “Experimental procedures”. Each data point repre-
ents meanSE from at least seven cells. Asterisks indicate a signif-
cant difference as compared with control (* P0.05; ** P0.01). Fors
nterpretation of the references to color in this figure legend, the reader
s referred to the Web version of this article.verage h5-HT3AR desensitization time was prolonged by
pproximately five to six-fold in the presence of 5-HOID
nd after Noc treatment (Fig. 4B, solid bars). These phar-
acological manipulations also significantly reduced the
verage percent inhibition by 1 M CBD from 793%
(control) to 282% and 296% (Fig. 4B, open bars).
These values were significantly different (P0.01, one-
way ANOVA followed by Dunnett’s posthoc test, n11).
Consistent with our previous study (Hu et al., 2006), the
decay of 5-HT-activated current slowed significantly in
HEK 293 cells expressing the R427L mutant h5-HT3ARs.
n these cells, the average percent inhibition of I5-HT by
CBD was only 182%, which was significantly less than
CBD inhibition of the WT receptors (P0.01, one-way
ANOVA followed by Dunnett’s posthoc test, n9).
Levels of functional receptor expression alter
desensitization kinetics
Accumulating evidence has revealed that the desensitiza-
tion rate of GABAA, glycine, and 5-HT3 receptors varies
with the steady state receptor density (Chen et al., 2000;
Legendre et al., 2002; Boileau et al., 2005; Xiong et al.,
2008). Xenopus ooyctes have been widely used as ex-
ression system in the studies of 5-HT3 receptor function-
ality. Moreover, one advantage of using Xenopus oocytes
is that the expression level of 5-HT3 receptor protein can
be relatively precisely manipulated. Our previous study
has shown the relationship between amount of cRNA in-
jected and receptor expression in oocytes (Xiong et al.,
2008). So to explore the interrelationship between func-
tional h5-HT3AR expression level, desensitization kinetics
nd CBD/THC-induced inhibiting effect on I5-HT, we in-
jected different concentrations (1, 10, and 100 ng) of h5-
HT3A subunit cRNA into Xenopus oocytes. In these cells,
he decays of currents activated by prolonged application
f 5-HT appeared to be different (Fig. 5A). By increasing
he concentrations of h5-HT3AR cRNAs injected into
ocytes, the receptor desensitization time increased (Fig.
B; r0.64, linear regression, P0.01). Thus, h5-HT3AR
esensitization varied with functional expression of the
eceptors expressed in Xenopus oocytes.
BD and THC-induced inhibition is correlated with
eceptor expression
ext we investigated if alteration of receptor density can
hange CBD inhibition. We observed that THC and CBD
nhibited h5-HT3AR-mediated current in a manner that de-
ended on the amount of h5-HT3AR-cRNA injected into the
oocytes (Fig. 6A). To investigate the nature of CBD and
THC inhibition, we first calculated the average percentage
inhibition of 5-HT current peak. The inhibition by CBD and
THC was the strongest at the lowest level of receptor
expression (Fig. 6B). For instance, the magnitudes of av-
erage inhibition by 10 M CBD and THC were 574% and
73% of control in oocytes injected with 1 ng of h5-
T3AR-cRNA, whereas the magnitudes of the inhibition
were only 162% and 131% of control in oocytes in-
jected with 100 ng of h5-HT3AR-cRNA. These values were
ignificantly different (one-way ANOVA followed by Dun-
c
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between the levels of receptor cRNA injection and receptor desensi-
tization time constant (Linear regression, P0.01).
meanSE from at least five oocytes. (C) Bar graphs represent average p
represents meanSE from at least five oocytes.
W. Xiong et al. / Neuroscience 184 (2011) 28–37 33nett’s posthoc test against, P0.001, n6). Next, we cal-
culated the average percentage inhibition of 5-HT integral
current by measuring current area. The result was found to
be similar to that of CBD and THC inhibition of 5-HT
current peak (Fig. 6C). Correlation analysis showed that
the magnitude of current peak inhibition produced by 10
M THC was strongly correlated with the amount of the
RNA injected into the oocytes (Fig. 7A, linear regression,
0.001) and the current activated by 30 M 5-HT (Fig.
B; linear regression, P0.01). The magnitude of current
eak inhibition produced by 10 M CBD was also strongly
correlated with the amount of the cRNA injected into the
oocytes (Fig. 7C, linear regression, P0.001) and the
current activated by 30 M 5-HT (Fig. 7D; P0.01).
CBD and THC-induced inhibition is correlated with
receptor desensitization
The above observations suggest that the levels of re-
ceptor expression alter receptor desensitization and the
magnitude of inhibition of h5-HT3ARs induced by THC-
and CBD. In view of these findings, we predicted that
CBD and THC-induced inhibition should be correlated
with receptor desensitization in cells injected with differ-
ent concentrations of h5-HT3AR-cRNA. Indeed, a corre-
ation was observed between the magnitude of THC-
Fig. 8A) or CBD (Fig. 8B)-induced inhibition and recep-
or desensitization time (linear regression, P0.01).
oreover, the receptor desensitization rate was signifi-
antly increased after application of THC/CBD, respec-
ively. Interestingly, we found a correlation between the
xpression. (A) Tracings showing preincubation (10 min) of CBD and
ously injected with 100 ng (upper), 10 ng (middle) and 1 ng (lower)
tion of peak current by CBD and THC. Each data point representsFig. 5. Receptor desensitization kinetics are correlated with functional
receptor expression. (A) Tracings of 5-HT-activated currents in Xeno-
us oocytes injected with different amount of h5-HT3A receptor cRNA.
The arrows indicate the amount of injected cRNA. (B) CorrelationFig. 6. CBD and THC-induced inhibition varies with the functional receptor e
THC induced inhibition of 5-HT-activated currents in Xenopus oocytes previ
of h5-HT3A receptor cRNA. (B) Bar graphs represent average percent inhibiercent inhibition of I5-HT area by CBD and THC. Each data point
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W. Xiong et al. / Neuroscience 184 (2011) 28–3734THC- (Fig. 8C) or CBD (Fig. 8D)-induced inhibition and
the receptor desensitization even after THC/CBD appli-
cation (linear regression, P0.001). In contrast, no sig-
nificant correlations were found between receptor acti-
vation time and THC- or CBD-induced inhibition (data
not shown).
DISCUSSION
The data presented in this study have shown that a
nonpsychotropic cannabinoid, CBD, inhibited h5-
HT3ARs in a concentration-dependent manner. The
C50 for CBD inhibition was 310 nM, which is within the
oncentration range (0.1–1 M) of CBD to produce neu-
oprotection, anticonvulsant, anxiolytic, and antipsy-
hotic effects (Pertwee, 2005). The inhibition by CBD
as independent of agonist concentration, suggesting
hat CBD is an apparent noncompetitive inhibitor of
-HT3ARs. This is consistent with previous findings on
HC inhibition of 5-HT3A receptors (Barann et al., 2002).
lthough CBD shares a high degree of structural simi-
arity with THC, there is strong evidence that CBD does
ot activate CB1 and CB2 receptors (Pertwee, 2005). It
s also unlikely that CBD-induced inhibition of h5-
T3ARs is mediated via endogenous cannabinoid and
apsaicin receptors since CBD did not stimulate [35S]-
Fig. 7. CBD and THC inhibition correlates with the levels of functio
induced by 10 M THC and the concentration of h5-HT3A receptor cR
epresents meanSE from at least seven oocytes. (B) Correlation b
mplitude activated by a maximally-effective concentration of 5-HT (10
(linear regression, P0.01, n24). (C) Correlation between the magn
RNA injected into oocytes (linear regression, P0.001, n4). Each
etween the extent of CBD-induced inhibition of h5-HT3ARs and curren
n oocytes previously injected with a different amount of h5-HT3AR-cRTP-s binding. sThe precise mechanism underlying CBD and THC
nhibition of 5-HT3Rs is unclear. Our study has sug-
gested that receptor desensitization critically contributes
to the magnitude of cannabinoid inhibition. Both THC
and CBD accelerated receptor desensitization. The sen-
sitivity of h5-HT3ARs to CBD- and THC-induced inhibi-
ion varied with different receptor desensitization rates.
or example, Noc and 5-HOID treatment slowed 5-HT3A
receptor desensitization and significantly reduced CBD
and THC-induced inhibition. Similarly, a point-mutation
of R427 in the large cytoplasmic domain of the 5-HT3A
subunit was also found to slow receptor desensitization
and attenuate CBD inhibition. Conversely, reducing re-
ceptor expression at the cell surface accelerated recep-
tor desensitization kinetics in Xenopus oocytes express-
ing h5-HT3ARs. In these cells, CBD-induced inhibition of
I5-HT increased. Overall, the magnitude of CBD and THC
nhibition was correlated with the extent of receptor
esensitization.
Desensitization plays a critical role in the regulation
f neuronal excitability and the efficacy of synaptic
ransmission (Jones and Westbrook, 1996; Giniatullin et
l., 2005). CBD and THC altered 5-HT3A receptor de-
ensitization kinetics without changing activation kinet-
cs. This observation is consistent with a previous study
tor expression. (A) Correlation between the magnitude of inhibition
ted into oocytes (linear regression, P0.001, n4). Each data point
e extent of THC-induced inhibition of 5-HT3A receptors and current
oocytes previously injected with different amounts of h5-HT3AR-cRNA
nhibition induced by 10 M CBD and the concentration of h5-HT3AR-
t represents meanSE from at least seven oocytes. (D) Correlation
de activated by a maximally-effective concentration of 5-HT (100 M)
ar regression, P0.01, n15).nal recep
NA injec
etween th
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3H]-GR65630 in HEK 293
cells expressing h5-HT3ARs (Barann et al., 2002). It is
lausible to predict that because CBD and THC inhibited
-HT3ARs, at least in part, by accelerating the rate of
eceptor desensitization, the energy barrier that governs
he channels from the open state to the desensitization
tate is critical for the potency of CBD and THC.
Our study has shown that the ability of CBD and THC
o inhibit 5-HT3ARs varies with receptor density at the cell
membrane surface. This observation is potentially impor-
tant since there are multiple factors regulating 5-HT3AR
density at synaptic membrane surfaces under physiologi-
cal and pathological processes. For instance, the expres-
sion levels of surface 5-HT3ARs were altered by activation
f protein kinases (Sun et al., 2003), cytoskeleton proteins
Emerit et al., 2005; Niesler et al., 2007), and naturally
ccurring genetic variants (Niesler et al., 2007). The ex-
ression level of 5-HT3Rs was elevated in serotonin trans-
orter deficient mice, suggesting that the extracellular con-
entration of 5-HT also influenced receptor density (Moss-
er et al., 2004). Collectively, these factors could
etermine the sensitivity of 5-HT3Rs to cannabinoid-in-
uced inhibiting effect.
How receptor density change alters the cannabinoid
nhibition is unclear. One possible explanation is that low
ensity receptors tend to enter the desensitization state
ith less energy barrier. This idea is consistent by a
ecent study showing that over-expression of the light
hain of the microtubule-associated protein 1B reduced
teady state receptor density at the cell surface and
ccelerated receptor desensitization kinetics (Sun et al.,
Fig. 8. Receptor desensitization correlates with THC and CBD inhib
average percentage of inhibition by THC/CBD (linear regression, P
application and average percentage of inhibition by THC/CBD (linear008). Similar observations were reported in the studies tf GABAARs in which receptor desensitization was mod-
ulated by different levels of the steady state density of
GABAA receptors at the cell surfaces (Chen et al., 2000;
Petrini et al., 2003; Boileau et al., 2005). There is also
evidence showing that desensitization of glycine recep-
tors varies with receptor density (Legendre et al., 2002).
One can ask if CBD and THC are open channel
lockers (OCB) of 5-HT3 receptors because the inhibi-
tion induced by both compounds developed and re-
versed slowly. However, our experimental data do not
favor this idea. An OCB should maximize its blocking
effect when channels open. With an OCB the inhibition
of peak current should be greater at higher agonist
concentrations, as the availability of the binding site
increases with increasing concentration. In addition,
blocking a channel at the open state by a given OCB
usually slows receptor desensitization. Neither of these
scenarios occurred in CBD-induced inhibition as CBD
inhibition was independent on agonist concentrations
and was associated with an acceleration of receptor
desensitization. Moreover, the blocking effect induced
by CBD appeared to develop before 5-HT was present,
which does not fit to the use-dependence, a typical
character of an OCB.
CONCLUSION
We conclude that CBD inhibits h5-HT3ARs and acceler-
tes receptor desensitization. The ability of inhibition by
BD and THC is highly dependent on receptor desen-
itization rate. Such a mechanism could be applicable to
B) Correlation between receptor desensitization time constant and
C, D) Correlation between receptor desensitization after THC/CBD
n, P0.01).ition. (A,he effects of endo/exocannabinoid-induced modulation
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W. Xiong et al. / Neuroscience 184 (2011) 28–3736of other members of the LGIC superfamily since anan-
damide has been shown to accelerate 5-HT3A, glycine
nd nAChR desensitization (Barann et al., 2002; Lozo-
aya et al., 2005; Spivak et al., 2007). Both CBD and
HC exert strong antinociceptive and antiemetic effects
Pacher et al., 2006). Inhibition of h5-HT3ARs by CBD
nd THC may contribute to the therapeutic mechanisms
f cannabinoids for control of pain, emesis, and other
eurological disorders.
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